Uracil and tegafur (in a molar ratio of 4:1 [UFT]) plus calcium folinate comprise the components of the oral agent, Orzel, which appears to have activity comparable to intravenously administered 5-fluorouracil. This article
Juergen Dethling, MD
Advertisement
Articles by Juergen Dethling, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Tocilizumab Supports Outpatient Bispecific Antibody Use in Multiple Myeloma
2
Perioperative Apalutamide Shifts Standard in Localized, High-Risk Prostate Cancer
3
ASCENT-04 Subgroup Analysis Yields Consistent PFS Benefits in Metastatic TNBC
4
HC-7366/Belzutifan Exhibits Manageable Safety Profile in Advanced RCC
5